Clinical Trials Sponsored by Signe Harder
Total 1930 results
-
Dana-Farber Cancer InstituteAstraZenecaCompletedMuscle Invasive Bladder CancerUnited States
-
Dana-Farber Cancer InstituteSanofiCompletedGastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Small Bowel CancerUnited States
-
Marker Therapeutics AGTerumo BCTCompleted
-
Dana-Farber Cancer InstituteNovartisTerminatedMetastatic Hormone-Receptor-Positive (HR+) Breast Cancer | HER2-Negative Breast Cancer | Metastatic Epithelial Ovarian CancerUnited States
-
Dana-Farber Cancer InstituteSanofiCompletedProstate CancerUnited States
-
Dana-Farber Cancer InstituteAstraZenecaCompleted
-
University of Mary Hardin-BaylorCompletedSurface Electromyography | Muscular FatigueUnited States
-
Dana-Farber Cancer InstituteBayerCompletedMetastatic Renal Cell CarcinomaUnited States
-
Henrik GudbergsenCompletedUltrasound of the Knee in Obese Patients With Knee Osteoarthritis; Weight Maintenance (US-LOSEIT-II)Obesity | OsteoarthritisDenmark
-
Henrik GudbergsenCompletedObesity | OsteoarthritisDenmark
-
Dana-Farber Cancer InstituteAmgenCompletedWaldenstrom's MacroglobulinemiaUnited States
-
Henrik GudbergsenUnknownObesity | OsteoarthrtisDenmark
-
Dana-Farber Cancer InstituteAmgenCompleted
-
Stephen Robert MarderNot yet recruitingPost Traumatic Stress DisorderUnited States
-
Haider MahdiDr. Reddys Laboratories, SARecruitingEpithelial Ovarian CancerUnited States
-
Dana-Farber Cancer InstituteImmunityBio, Inc.Not yet recruitingOvarian Cancer | Platinum-resistant Ovarian Cancer | Ovarian Carcinoma | Recurrent Ovary Cancer | Ovarian Carcinoma, RecurrentUnited States
-
Universiti Putra MalaysiaNorthern Border UniversityRecruitingObesity | Physical InactivityMalaysia
-
Mallory HackerNot yet recruiting
-
Dana-Farber Cancer InstituteNest GenomicsRecruitingGenetic Predisposition to Disease | Genetic PredispositionUnited States
-
Dana-Farber Cancer InstituteCelldex TherapeuticsRecruitingMelanoma | Metastatic MelanomaUnited States
-
Dana-Farber Cancer InstituteGenentech, Inc.RecruitingBreast Cancer | HER2-positive Breast Cancer | Hormone Receptor Positive Breast Cancer | Invasive Carcinoma of the Breast | Node Negative Breast Cancer | Micrometastasis Breast CancerUnited States
-
Dana-Farber Cancer InstituteIncyte CorporationActive, not recruitingInflammatory Breast Cancer (IBC)United States
-
Dana-Farber Cancer InstituteRoche-GenentechActive, not recruitingGraft vs. Host DiseaseUnited States
-
Dana-Farber Cancer InstituteHiberCell, Inc.CompletedRelapsed/Refractory Indolent B Cell Non-Hodgkin LymphomasUnited States
-
Dana-Farber Cancer InstituteGenentech, Inc.Active, not recruitingAdvanced Non-Clear Cell Kidney CancerUnited States
-
Dana-Farber Cancer InstituteTesaro, Inc.Active, not recruiting
-
Dana-Farber Cancer InstituteEisai Inc.Active, not recruitingInflammatory Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastUnited States
-
Dana-Farber Cancer InstituteAmbry GeneticsCompletedBreast Cancer | Pancreatic Cancer | Ovarian Cancer | Metastatic Prostate CancerUnited States
-
Dana-Farber Cancer InstituteGenentech, Inc.Active, not recruitingChronic Lymphocytic LeukemiaUnited States
-
Vander Haegen MarieWithdrawn
-
University of MichiganFarmer Family FoundationTerminatedParkinson Disease | Lewy Body Dementia | Parkinson Disease DementiaUnited States
-
Dana-Farber Cancer InstituteTakeda; CelgeneActive, not recruitingSmoldering Multiple MyelomaUnited States
-
Dana-Farber Cancer InstituteEntrinsic HealthCompletedMultiple Myeloma | Non-Hodgkin's LymphomaUnited States
-
Dana-Farber Cancer InstituteJanssen, LPCompletedWaldenström MacroglobulinemiaUnited States
-
Dana-Farber Cancer InstituteMedivation, Inc.CompletedMetastatic Castration-resistant Prostate CancerUnited States
-
Tatiana Besse-HammerCompleted
-
Dana-Farber Cancer InstituteGenentech, Inc.TerminatedALK-positive Non-small Cell Lung Cancer (NSCLC) | RET-positive Non-small Cell Lung Cancer (NSCLC) | RET-positive Thyroid CancerUnited States
-
Dana-Farber Cancer InstituteBayer; PfizerCompletedGastrointestinal Stromal TumorUnited States
-
Dana-Farber Cancer InstituteIncyte CorporationCompletedMetastatic Breast Cancer | Recurrent Breast CancerUnited States
-
Dana-Farber Cancer InstituteNovartis; AstraZenecaCompleted
-
Dana-Farber Cancer InstituteJanssen PharmaceuticalsTerminatedProstate CancerUnited States
-
Dana-Farber Cancer InstituteCelgene CorporationTerminatedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CarcinomaUnited States
-
Hadeer Ashraf Hassan RoushdyUnknown
-
VA New York Harbor Healthcare SystemCompletedSmoking Cessation | HypertensionUnited States
-
AEterna ZentarisDana-Farber Cancer InstituteCompletedRenal Cell CarcinomaUnited States
-
Fate TherapeuticsDana-Farber Cancer InstituteCompletedHematologic Malignancies | Allogeneic Stem Cell TransplantationUnited States
-
VA New York Harbor Healthcare SystemCompleted
-
Parker, William H., M.D.Ethicon, Inc.CompletedStroke | Cancer | Breast Cancer | Death | Ovarian Cancer | Coronary Heart Disease | Hip FractureUnited States
-
dr. Laura C. G. de Graaff-HerderRecruitingDisorders of Sex Development | Congenital Adrenal Hyperplasia | Tuberous Sclerosis | Kallmann Syndrome | Prader-Willi Syndrome | Neurofibromatosis | Rett Syndrome | 22q11 Deletion Syndrome | Turner Syndrome | Noonan Syndrome | Allan-Herndon-Dudley Syndrome | Saethre-Chotzen Syndrome | Congenital Hypopituitarism | Cornelia... and other conditionsNetherlands
-
dr. Laura C. G. de Graaff-HerderNot yet recruitingCongenital Adrenal Hyperplasia | Hypogonadotropic Hypogonadism | Growth Hormone Deficiency | Turner Syndrome | Addison's Disease | Klinefelter Syndrome | Combined Pituitary Hormone Deficiency | Androgen Insensitivity Syndrome | Thyroid DysgenesisSpain, United Kingdom, Belgium, Netherlands